CryoXtract Blog

Listen to the Audio: Interview with Dee McGarvey, Director, CHTN Eastern Division, University of PA

Posted by Larry Chin on May 23, 2014 9:11:00 AM

The following are indexed audio files of the full interview between Larry Chin, Vice President of Business Development at CryoXtract, and Dee McGarvey, Director, CHTN Eastern Division, University of Pennsylvania.

Read More

Topics: Sample Integrity, ISBER, legacysamples, biobanks, biobanking

Listen to the Audio: Interview with Andy Zaayenga, Managing Director of SmarterLab and President-Elect of ISBER, 2014-2015

Posted by Larry Chin on May 2, 2014 8:14:05 AM

The following are audio files of the full interview conducted by Larry Chin, Vice President of Business Development at CryoXtract, with Andy Zaayenga, Managing Director of SmarterLab and President-Elect of ISBER, 2014-2015. You can also read the full transcript below.

Challenges Facing the Biobanking Industry:

In a recent interview with CryoXtract’s Larry Chin, Andy Zaayenga, Managing Director of SmarterLab and incoming President of ISBER, discusses the top three challenges facing the biobanking industry today. He cites problems with sample utilization and acceptance of biobanks by the general population as key concerns. Both of these relate to the third problem of biobanks operating alone in silos. Without solid systems of communication and standardization of infrastructure and procedures, improving sample utilization and the public perception of the industry is difficult. ISBER is one organization working towards addressing these issues through initiatives such as its upcoming biorepository locator.

Needs of the Biobanking Industry:

Andy Zaayenga continues his discussion of the top three gaps and unmet needs of biobanks by arguing for improved quality assurance and control in order to preserve sample suitability for research. He again calls for standardization and harmonization of quality assurance procedures, data structures, and annotation of samples to increase accessibility and cross-utilization of samples.  Finally, he highlights ISBER's published best practices and self-assessment tools as key answers to another major gap in the industry. 

Read More

Topics: ISBER, Andy Zaayenga, biospecimens, legacysamples, biobanks, biorepository, biobanking